TCL Archive AACR, ASCO, ONS Flex Political Muscles, Seek Changes In Cancer Act, Other Legislation, Funding Of Grants May 7, 1982
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million June 21, 1974